Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2006 Jun;59(6):624-30.
doi: 10.1136/jcp.2005.033167.

Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q

F Al-Mulla  1 , S AlFadhli, A H Al-Hakim, J J Going, M S Bitar
Affiliations
Multicenter Study

Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q

F Al-Mulla et al. J Clin Pathol. 2006 Jun.

Abstract

Objective: To investigate the prognostic value for loss of heterozygosity (LOH) of chromosomes 4 and 14q in early-stage colorectal cancer (CRC).

Methods: A total of 70, largely microsatellite stable, tumours and their corresponding normal mucosa were subjected to microdissection and analysed for LOH at chromosomes 4 and 14q by using 13 highly polymorphic microsatellite markers. LOH was correlated with the survival of the patients, using univariate, multivariate and Kaplan-Meier's survival curves.

Result: LOH at D4S2935, D4S1579 and D4S1595 on chromosome 4 was significantly associated with metastatic recurrence of early-stage CRC. For chromosome arm 14q, two minimal regions of deletion were associated with metastatic recurrence and mapped to neighbouring markers D14S275/D14S49 at 14q12-13 and D14S65/D14S250 at 14q32. High-level loss (loss of five to eight of the informative microsatellite markers) on both chromosomes 4 and 14q, to be an independent prognostic indicator in early-stage CRC was shown by multivariate analysis.

Conclusion: Determining the LOH of chromosomes 4 and 14q and their extent in primary tumours of patients with early-stage CRC may constitute a molecular signature of metastatic recurrence. This may be achieved if new finding sheds light on the treatment of this subgroup of patients that have been largely ignored.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

References

    1. Kahlenberg M S, Sullivan J M, Witmer D D.et al Molecular prognostics in colorectal cancer. Surg Oncol 200312173–186. - PubMed
    1. Compton C C. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol 200316376–388. - PubMed
    1. Ovaska J, Jarvinen H, Kujari H.et al Follow‐up of patients operated on for colorectal carcinoma. Am J Surg 1990159593–596. - PubMed
    1. Olson R M, Perencevich N P, Malcolm A W.et al Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer 1980452969–2974. - PubMed
    1. Petersen V C, Baxter K J, Love S B.et al Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 20025165–69. - PMC - PubMed

Publication types